| Drug Name |
Buserelin acetate |
| Drug ID |
BADD_D00315 |
| Description |
Buserelin is a synthetic peptide analog of the luteinizing hormone-releasing hormone (LHRH) agonist, which stimulates the pituitary gland's gonadotrophin-releasing hormone receptor (GnRHR). It is used in prostate cancer treatment. |
| Indications and Usage |
Buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. |
| Marketing Status |
approved; investigational |
| ATC Code |
L02AE01 |
| DrugBank ID |
DB06719
|
| KEGG ID |
D01831
|
| MeSH ID |
D002064
|
| PubChem ID |
50224
|
| TTD Drug ID |
D04GSY
|
| NDC Product Code |
71052-358 |
| UNII |
13U86G7YSP
|
| Synonyms |
Buserelin | Buserelin Acetate | Acetate, Buserelin | Suprefact | Profact | Receptal | Tiloryth | Suprecur | Bigonist | HOE-766 | HOE 766 | HOE766 |
